IGF2BP2 and thyroid gland carcinoma: However, in select cancers, such as OV (HR = 0.74, log-rank < 0.05) and thyroid carcinoma (THCA) (HR = 0.2, log-rank < 0.05), higher IGF2BP2 was correlated with increased survival (Figure 6J,K).